Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (1): 48-53. doi: 10.19723/j.issn.1671-167X.2022.01.008

Previous Articles     Next Articles

Comparison of initial periodontal therapy and its correlation with white blood cell level in periodontitis patients with or without diabetes mellitus

XU Xin-ran,HUO Peng-cheng,HE Lu(),MENG Huan-xin,ZHU Yun-xuan,JIN Dong-si-qi   

  1. Department of Periodontology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2021-10-10 Online:2022-02-18 Published:2022-02-21
  • Contact: Lu HE E-mail:helubj@tom.com

RICH HTML

   

PDF (PC)

Abstract:

Objective: To compare the clinical efficacy of initial periodontal therapy in periodontitis patients with or without type 2 diabetes mellitus and its correlation with white blood cell counts. Methods: In this study, 32 chronic periodontitis patients without systemic disease (CP group) and 27 chronic periodontitis patients with type 2 diabetes mellitus (CP+DM group) were enrolled. At admission, all the patients went through periodontal examination and fasting blood examination(baseline). Probing depth (PD), attachment loss (AL), bleeding index (BI), plaque index (PLI), white blood cells (WBC) counts and fasting blood glucose (FBG) were recorded respectively, while hemoglobin A1c (HbA1c) was recorded only in CP+DM group. After that, initial periodontal therapy was performed. All the tests were repeated 3 and 6 months after treatment. The changes of periodontal clinical indexes and WBC levels were compared between the two groups before and after treatment, and the correlation between WBC and periodontal clinical indexes and glucose metabolism indexes were analyzed by generalized linear mixed model. Results: At baseline, the periodontal inflammation and destruction were similar in CP and CP+DM group, but the WBC level was significantly higher in CP+DM groups [(6.01±1.26)×109/L vs. (7.14±1.99)×10 9/L, P=0.01]. After 3 and 6 months of initial periodontal therapy, the mean PD, AL, BI, and PLI in CP+DM and CP groups were significantly lower than the baseline, and the PD in CP+DM group was further decreased by 6 months compared with 3 months [(3.33±0.62) mm vs. (3.61±0.60) mm, P<0.05]. However, none of these periodontal indexes showed significant difference between the two groups by 3 or 6 months. In CP+DM group, HbA1c at 3 months and 6 months were significantly lower than the baseline [(7.09±0.79)% vs. (7.64±1.16)%, P<0.05; (7.06±0.78)% vs. (7.64±1.16)%, P<0.05], and FBG was significantly lower than the baseline by 6 months [(7.35±1.14) mmol/L vs. (8.40±1.43) mmol/L, P<0.05]. The WBC level in CP group was significantly lower than the baseline level by 3 months [(5.35±1.37)×10 9/L vs. (6.01±1.26)×10 9/L, P<0.05], while that in CP+DM group was significantly lower than the baseline level by 6 months [(6.00±1.37)×10 9/L vs. (7.14±1.99)×10 9/L, P<0.05]. The analysis of genera-lized linear mixed model showed that WBC level was significantly positively correlated with PD and FBG (P<0.05). Conclusion: Initial periodontal therapy can effectively improve the periodontal clinical status of patients with or without type 2 diabetes mellitus, and have benefits on glycemic control in diabetic patients. However, the response of periodontal indexes and WBC level to initial therapy were relatively delayed in diabetic patients. WBC plays an important role in the correlation between diabetes mellitus and periodontitis.

Key words: Periodontitis, Diabetes mellitus, type 2, Dental scaling, Periodontal index

CLC Number: 

  • R781.4

Table 1

General characteristic and clinical indexes at baseline of patients in CP and CP+DM groups"

Items CP group
(n=32)		 CP+DM group
(n=27)		 P
Age/years 47.16±5.35 54.22±7.87 <0.001
Male 13 (40.6) 18 (66.7) 0.046
BMI/(kg/m2) 23.48±2.11 24.25±2.26 0.182
WHR 0.88±0.06 0.88±0.03 0.614
PD/mm 4.68±0.59 4.63±0.95 0.821
AL/mm 4.43±1.20 4.56±0.99 0.669
BI 3.20±0.63 2.90±0.73 0.089
PLI 2.97±0.12 2.85±0.21 0.009
WBC/(×109/L) 6.01±1.26 7.14±1.99 0.010
FBG/(mmol/L) 5.20±0.35 8.40±1.43 <0.001
HbA1c/% - 7.64±1.16

Table 2

Influence of initial periodontal therapy on periodontal indexes, glycemic parameters and WBC levels"

Items Baseline 3 months 6 months Δ3 months Δ6 months
PD/mm
CP group 4.68±0.59 3.62±0.64* 3.47±0.57* 1.07±0.63 1.20±0.68
CP+DM group 4.63±0.95 3.61±0.60* 3.33±0.62*§ 1.02±0.86 1.30±0.84
AL/mm
CP group 4.43±1.20 3.87±1.07* 3.58±0.81*§ 0.56±0.66 0.85±0.66
CP+DM group 4.56±0.99 3.79±0.83* 3.76±0.86* 0.77±0.85 0.80±0.62
BI
CP group 3.20±0.63 2.09±0.61* 2.03±0.55* 1.12±0.82 1.18±0.82
CP+DM group 2.90±0.73 1.97±0.56* 1.84±0.42* 0.93±0.85 1.06±0.68
PLI
CP group 3.00±0.22 2.59±0.57* 1.85±0.75*§ 0.41±0.52 1.15±0.73
CP+DM group 2.85±0.21# 2.42±0.58* 2.03±0.65*§ 0.43±0.52 0.81±0.65
WBC/(×109/L)
CP group 6.01±1.26 5.35±1.37* 5.51±1.51 0.66±1.11 0.50±1.18
CP+DM group 7.14±1.99# 6.57±1.68 6.00±1.37* 0.57±2.20 1.14±1.80
FBG/(mmol/L)
CP group 5.20±0.35 5.20±0.32 5.33±0.42 0.00±0.31 -0.13±0.47
CP+DM group 8.40±1.43# 7.72±1.40# 7.35±1.14*# 0.68±1.52# 1.05±1.59#
HbA1c/%
CP group - - - - -
CP+DM group 7.64±1.16 7.09±0.79* 7.06±0.78* 0.55±0.78 0.58±0.83

Table 3

GLMM analysis of WBC with clinical periodontal parameters and FBG"

Parameter β SE t/Z P 95%CI
Model 1
Intercept 3.19 0.77 4.12 <0.001 1.66 to 4.71
PD 0.57 0.22 2.56 0.011 0.13 to 1.00
FBG 0.28 0.09 3.25 0.001 0.11 to 0.45
Model 2
Intercept 3.37 0.99 3.39 0.001 1.41 to 5.33
PD 0.55 0.22 2.48 0.014 0.11 to 0.99
FBG 0.27 0.09 2.98 0.003 0.09 to 0.44
Model 3
Intercept 4.10 2.34 1.75 0.082 -0.52 to 8.72
PD 0.53 0.22 2.36 0.019 0.09 to 0.96
FBG 0.29 0.09 3.33 0.001 0.12 to 0.46
Model 4
Intercept 4.73 2.47 1.91 0.058 -0.16 to 9.61
PD 0.45 0.23 1.98 0.050 0.001 to 0.90
FBG 0.26 0.09 2.94 0.004 0.09 to 0.44
[1] Graves DT, Ding Z, Yang Y. The impact of diabetes on periodontal diseases[J]. Periodontol 2000, 2020, 82(1):214-224.
doi: 10.1111/prd.12318 pmid: 31850631
[2] Genco RJ, Graziani F, Hasturk H. Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus[J]. Periodontol 2000, 2020, 83(1):59-65.
doi: 10.1111/prd.v83.1
[3] Costa FO, Cota LM, Lages EP, et al. Progression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: A 5-year follow-up study[J]. J Periodontol, 2013, 84(5):595-605.
doi: 10.1902/jop.2012.120255
[4] Mirza RE, Fang MM, Weinheimer-Haus EM, et al. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice[J]. Diabetes, 2013, 63(3):1103-1114.
doi: 10.2337/db13-0927
[5] da Cruz GA, de Toledo S, Sallum EA, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus[J]. J Periodontol, 2008, 79(7):1150-1157.
doi: 10.1902/jop.2008.070503
[6] Correa F, Goncalves D, Figueredo C, et al. The short-term effectiveness of non-surgical treatment in reducing levels of interleukin-1beta and proteases in gingival crevicular fluid from patients with type 2 diabetes mellitus and chronic periodontitis[J]. J Periodontol, 2008, 79(11):2143-2150.
doi: 10.1902/jop.2008.080132
[7] Goncalves D, Correa F, Khalil NM, et al. The effect of non-surgical periodontal therapy on peroxidase activity in diabetic patients: A case-control pilot study[J]. J Clin Periodontol, 2010, 35(9):799-806.
doi: 10.1111/cpe.2008.35.issue-9
[8] Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes[J]. Diabetes, 2002, 51(2):455-461.
pmid: 11812755
[9] Zhang H, Zhen Y, Zhang W, et al. White blood cell subtypes and risk of type 2 diabetes[J]. J Diabetes Complications, 2016, 31(1):31-37.
doi: 10.1016/j.jdiacomp.2016.10.029
[10] NibaliI L, D’Aiuto F, Griffiths G, et al. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: A case-control study[J]. J Clin Periodontol, 2010, 34(11):931-937.
doi: 10.1111/cpe.2007.34.issue-11
[11] Wang X, Meng H, Xu L, et al. Mean platelet volume as an inflammatory marker in patients with severe periodontitis[J]. Platelets, 2015, 26(1):67-71.
doi: 10.3109/09537104.2013.875137
[12] Sonoki K, Nakashima S, Takata Y, et al. Decreased lipid peroxidation following periodontal therapy in type 2 diabetic patients[J]. J Periodontol, 2006, 77(11):1907-1913.
pmid: 17076618
[13] Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis[J]. J Clin Periodontol, 2007, 34(10):835-843.
pmid: 17850602
[14] 徐菁玲, 孟焕新, 李峥, 等. 牙周基础治疗对2型糖尿病伴慢性牙周炎患者血糖代谢指标及血清生化指标的影响[J]. 北京大学学报(医学版), 2013, 45(1):27-32.
[15] Suvan J, Harrington Z, Petrie A, et al. Obesity as predictive factor of periodontal therapy clinical outcomes: A cohort study[J]. J Clin Periodontol, 2020, 47(5):594-601.
doi: 10.1111/jcpe.13261 pmid: 31994205
[16] Retamal I, Hernandez R, Velarde V, et al. Diabetes alters the involvement of myofibroblasts during periodontal wound healing[J]. Oral Dis, 2020, 26(5):1062-1071.
doi: 10.1111/odi.v26.5
[17] Trombelli L, Simonelli A, Franceschetti G, et al. What periodontal recall interval is supported by evidence?[J]. Periodontol 2000, 2020, 84(1):124-133.
doi: 10.1111/prd.12340 pmid: 32844410
[18] Mauri-Obradors E, Merlos A, Estrugo-Devesa A, et al. Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial[J]. J Clin Periodontol, 2018, 45(3):345-353.
doi: 10.1111/jcpe.12858 pmid: 29265454
[19] Shiny A, Bibin YS, Shanthirani CS, et al. Association of neutrophil-lymphocyte ratio with glucose intolerance: An indicator of systemic inflammation in patients with type 2 diabetes[J]. Diabetes Technol Ther, 2014, 16(8):524-530.
doi: 10.1089/dia.2013.0264
[20] Cersosimo E, Defronzo RA. Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases[J]. Diabetes-Metab Res Rev, 2010, 22(6):423-436.
doi: 10.1002/(ISSN)1520-7560
[21] Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes[J]. Diabetes Care, 2004, 27(1):216-222.
doi: 10.2337/diacare.27.1.216
[22] Gao H, Xu J, He L, et al. Calprotectin levels in gingival crevicular fluid and serum of patients with chronic periodontitis and type 2 diabetes mellitus before and after initial periodontal therapy[J]. J Periodont Res, 2021, 56(1):121-130.
doi: 10.1111/jre.v56.1
[23] Gao H, Hou J, Meng H, et al. Proinflammatory effects and mecha-nisms of calprotectin on human gingival fibroblasts[J]. J Periodont Res, 2017, 52(6):975-983.
doi: 10.1111/jre.2017.52.issue-6
[1] Peiheng ZHANG, Ying GAO, Honghua WU, Jian ZHANG, Junqing ZHANG. Fulminant type 1 diabetes mellitus with acute pancreatitis: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 923-927.
[2] Yuru HU,Juan LIU,Wenjing LI,Yibing ZHAO,Qiqiang LI,Ruifang LU,Huanxin MENG. Relationship between short-chain fatty acids in the gingival crevicular fluid and periodontitis of stage Ⅲ or Ⅳ [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 332-337.
[3] Yujia MA,Ranli LU,Zechen ZHOU,Xiaoyi LI,Zeyu YAN,Yiqun WU,Dafang CHEN. Association between insomnia and type 2 diabetes: A two-sample Mendelian rando-mization study [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 174-178.
[4] Han ZHANG,Yixuan QIN,Diyuan WEI,Jie HAN. A preliminary study on compliance of supportive treatment of patients with periodontitis after implant restoration therapy [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 39-44.
[5] Chang SHU,Ye HAN,Yuzhe SUN,Zaimu YANG,Jianxia HOU. Changes of parameters associated with anemia of inflammation in patients with stage Ⅲ periodontitis before and after periodontal initial therapy [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 45-50.
[6] Lei BAO,Xia-xia CAI,Ming-yuan ZHANG,Lei-lei REN. Effect of vitamin D3 on mild cognitive impairment in type 2 diabetic mice and its possible mechanism [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 587-592.
[7] Xi-yan PEI,Wen YANG,Xiang-ying OUYANG,Feng SUN. Comparison of clinical effects between periodontal endoscopy aiding subgingival debridement and flap surgery [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 716-720.
[8] Xiao-yue ZHANG,Yu-xin LIN,Ying JIANG,Lan-chao ZHANG,Mang-yan DONG,Hai-yi CHI,Hao-yu DONG,Li-jun MA,Zhi-jing LI,Chun CHANG. Mediating effect of self-efficacy on self-management ability and self-management behavior in patients with type 2 diabetes mellitus [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 450-455.
[9] Huan YU,Ruo-tong YANG,Si-yue WANG,Jun-hui WU,Meng-ying WANG,Xue-ying QIN,Tao WU,Da-fang CHEN,Yi-qun WU,Yong-hua HU. Metformin use and risk of ischemic stroke in patients with type 2 diabetes: A cohort study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 456-464.
[10] Jing WEN,Xiang-ying OUYANG,Xi-yan PEI,Shan-yong QIU,Jian-ru LIU,Wen-yi LIU,Cai-fang CAO. Multivariable analysis of tooth loss in subjects with severe periodontitis over 4-year natural progression [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 70-77.
[11] WU Jun-hui,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,QIN Xue-ying,WANG Meng-ying,WANG Xiao-wen,WANG Jia-ting,HU Yong-hua. Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 249-254.
[12] ZHU Xiao-ling,LI Wen-jing,WANG Xian-e,SONG Wen-li,XU Li,ZHANG Li,FENG Xiang-hui,LU Rui-fang,SHI Dong,MENG Huan-xin. Gene polymorphisms of cytochrome B-245 alpha chain (CYBA) and cholesteryl ester transfer protein (CETP) and susceptibility to generalized aggressive periodontitis [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 18-22.
[13] GAO Hong-yu,MENG Huan-xin,HOU Jian-xia,HUANG Bao-xin,LI Wei. Expression and distribution of calprotectin in healthy and inflamed periodontal tissues [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 744-749.
[14] GUO Hong-ping,ZHAO Ai,XUE Yong,MA Liang-kun,ZHANG Yu-mei,WANG Pei-yu. Relationship between nutrients intake during pregnancy and the glycemic control effect in pregnant women with gestational diabetes mellitus [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 467-472.
[15] WU Jun-hui,CHEN Hong-bo,WU Yi-qun,WU Yao,WANG Zi-jing,WU Tao,WANG Meng-ying,WANG Si-yue,WANG Xiao-wen,WANG Jia-ting,YU Huan,HU Yong-hua. Prevalence and risk factors of osteoarthritis in patients with type 2 diabetes in Beijing, China from 2015 to 2017 [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 518-522.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd